Japanese encephalitis vaccine (live, attenuated)

DB16577InvestigationalVaccines

Japanese encephalitis vaccine (live, attenuated) is a live attenuated vaccine against Japanese encephalitis. A vaccine against an infection that causes brain swelling.

Also known as: Japanese encephalitis live attenuated strain sa 14-14-2 antigen · Japanese encephalitis live attenuated strain sa 14-14-2 vaccine · Japense encephalitis vaccine, live, attenuated

Resolves to

Compound

UNIIZZ1CP75F3U

What you can answer from here — as of April 02, 2025

10Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

6Marketed productsAcross 2 countries and 3 labellers

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Japanese encephalitis vaccine (live, attenuated), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account